KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Receivables (2018 - 2025)

Progyny (PGNY) has disclosed Receivables for 8 consecutive years, with $254.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables changed N/A to $254.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $254.2 million, a N/A change, with the full-year FY2025 number at $254.2 million, changed N/A from a year prior.
  • Receivables was $254.2 million for Q4 2025 at Progyny, down from $296.8 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $370.3 million in Q2 2024 to a low of $139.9 million in Q1 2021.
  • A 5-year average of $279.3 million and a median of $296.8 million in 2025 define the central range for Receivables.
  • Peak YoY movement for Receivables: skyrocketed 102.36% in 2022, then decreased 13.3% in 2025.
  • Progyny's Receivables stood at $158.3 million in 2021, then skyrocketed by 78.8% to $283.0 million in 2022, then increased by 1.41% to $287.0 million in 2023, then increased by 18.56% to $340.2 million in 2024, then dropped by 25.29% to $254.2 million in 2025.
  • Per Business Quant, the three most recent readings for PGNY's Receivables are $254.2 million (Q4 2025), $296.8 million (Q3 2025), and $321.1 million (Q2 2025).